Affiliation:
1. Department of Hepatogastroenterology, Theodor Bilharz Research Institute, Giza 12411, Egypt
Abstract
This is a case of remarkable alpha-fetoprotein in a female patient with known cryptogenic liver cirrhosis. Both ultrasound and triphasic computed tomography (CT) abdomen cannot diagnose or exclude hepatocellular carcinoma (HCC). It turns out to be a case of portal vein thrombosis and hepatic pseudo-infarction. It is better to postpone the therapeutic intervention, whether surgical or chemotherapeutic, in cases not confirmed to be HCC for at least 3 months to avoid misdiagnosis of hepatic pseudo-infarction.
Publisher
Open Exploration Publishing
Reference17 articles.
1. Li W, Liu K, Chen Y, Zhu M, Li M. Role of alpha-fetoprotein in hepatocellular carcinoma drug resistance. Curr Med Chem. 2021;28:1126–42.
2. Peng YC, Chan CS, Chen GH. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Hepatogastroenterology. 1999;46:3208–11.
3. Sherman M. Alphafetoprotein: an obituary. J Hepatol. 2001;34:603–5.
4. Gao F, Zhu HK, Zhu YB, Shan QN, Ling Q, Wei XY, et al. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern. Hepatobiliary Pancreat Dis Int. 2016;15:371–7.
5. Chan MY, She WH, Dai WC, Tsang SHY, Chok KSH, Chan ACY, et al. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong. Transl Gastroenterol Hepatol. 2019;4:52.